AstraZeneca Pharma India Limited (BOM:506820)
India · Delayed Price · Currency is INR 6,387.90
+93.00 (1.48%)
At close: Nov 6, 2026
AstraZeneca Pharma India Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 26,090 | 22,756 | 17,163 | 12,955 | 10,030 | 8,056 |
Revenue Growth | 30.05% | 32.59% | 32.48% | 29.17% | 24.50% | -0.98% |
Gross Profit Gross Profit Growth | 9,232 | 8,910 | 7,475 | 6,947 | 6,370 | 4,887 |
Operating Income Operating Income Growth | 2,375 | 2,337 | 2,148 | 1,714 | 1,489 | 693.6 |
Net Income Net Income Growth | 1,777 | 1,875 | 1,157 | 1,615 | 992.9 | 616 |
Earnings Per Share EPS Growth | 71.09 | 75.01 | 46.30 | 64.60 | 39.72 | 24.64 |
EPS Growth | -10.79% | 62.02% | -28.34% | 62.67% | 61.19% | -33.98% |
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 21,580 | 16,066 | 12,019 | 9,389 | 7,592 |
Outside India Outside India Growth | 1,176 | 1,097 | 936 | 640.5 | 464.3 |
Total Total Growth | 22,756 | 17,163 | 12,955 | 10,030 | 8,056 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 5,751 | 4,477 | 5,361 | 5,056 | 5,003 | 4,484 |
Total Debt Total Debt Growth | 962.1 | 1,107 | 357.3 | 45.9 | 72.1 | 86.3 |
Net Cash (Debt) Net Cash Growth | 4,789 | 3,371 | 5,004 | 5,010 | 4,931 | 4,398 |
Net Cash Growth | 31.16% | -32.64% | -0.11% | 1.59% | 12.13% | 29.27% |
Net Cash Per Share Net Cash Per Share Growth | 191.56 | 134.82 | 200.16 | 200.39 | 197.25 | 175.92 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 2,830 | -151.4 | 653.6 | 278.7 | 582.9 | 1,008 |
Capital Expenditures CapEx Growth | -168.6 | -15.6 | -17.5 | -107.6 | -85.2 | -96.2 |
Free Cash Flow Free Cash Flow Growth | 2,661 | -167 | 636.1 | 171.1 | 497.7 | 911.8 |
Free Cash Flow Growth | - | - | 271.77% | -65.62% | -45.42% | -6.07% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 35.39% | 39.15% | 43.55% | 53.63% | 63.51% | 60.66% |
Operating Margin | 9.10% | 10.27% | 12.52% | 13.23% | 14.84% | 8.61% |
Pretax Margin | 9.35% | 11.08% | 9.11% | 16.95% | 13.37% | 10.31% |
Profit Margin | 6.81% | 8.24% | 6.74% | 12.47% | 9.90% | 7.65% |
FCF Margin | 10.20% | -0.73% | 3.71% | 1.32% | 4.96% | 11.32% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 7, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 36.000 | 36.000 | 32.000 | 24.000 | 16.000 | 10.000 |
Dividend Per Share Growth | 12.50% | 12.50% | 33.33% | 50.00% | 60.00% | 400.00% |
Dividend Yield | 0.56% | 0.46% | 0.37% | 0.45% | 0.49% | 0.39% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 7, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 89.86 | 103.45 | 185.90 | 82.35 | 81.76 | 103.71 |
P/FCF Ratio | 60.01 | - | 338.25 | 777.38 | 163.12 | 70.07 |
PS Ratio | 6.12 | 8.53 | 12.54 | 10.27 | 8.09 | 7.93 |